Barnard R, Bundesen P G, Rylatt D B, Waters M J
Biochem J. 1985 Oct 15;231(2):459-68. doi: 10.1042/bj2310459.
We describe the use of four monoclonal antibodies (MAbs) to the rabbit liver growth hormone (GH) receptor and one raised against purified rat liver GH receptor to characterize liver receptor subtypes which differ in their hormone-binding regions. The anti-(rat liver GH receptor) MAb both inhibited and precipitated rat and rabbit GH receptors, but only one-half of 125I-oGH (ovine GH) binding to liver microsomes could be inhibited by excess antibody. Conversely, only one-half of 125I-anti-(rat GH receptor) MAb binding was inhibited by excess oGH and Scatchard plots for this MAb exhibited two components. Although only 50% of 125I-oGH binding to membranes was inhibited by this MAb, all solubilized receptor could be immunoprecipitated. We postulate two epitopes for the anti-(rat GH receptor) MAb, one located at the hormone-binding site (inhibitory site) and one elsewhere (immunoprecipitating site). A second, rabbit-specific antibody (MAb 7) inhibited 85% of hormone binding but only 30% of 125I-anti-(rat GH receptor) MAb binding to rabbit liver microsomes. A combination of this MAb with the anti-(rat GH receptor) MAb totally inhibited 125I-oGH binding. MAb 7 alone totally inhibited 125I-rat GH binding to rabbit liver microsomes, as it did with 125I-oGH binding to purified receptor. On the basis of these results and others we postulate three types of GH receptor in rabbit liver membranes and ascribe approximate extents of 125I-oGH binding to each. A cytosolic 'GH receptor' which is not poly(ethylene glycol)-precipitable is shown to share five epitopes with 'type 2' microsomal receptors. Purified plasma membrane and endoplasmic reticulum fractions derived from a rabbit liver microsomal preparation have identical antigenic characteristics with respect to the GH-binding region, indicating that the heterogeneity we describe is not related to receptor processing. Of the three types of GH receptor in the plasma membrane of the rabbit (and possibly rat) we postulate that one (type 1) corresponds to the GH receptor involved in stimulating growth and possesses all of the epitopes studied here. A second (type 2) appears to be identical with the cytosolic 'GH receptor' and lacks the epitope for the anti-(rat GH receptor) MAb in the hormone binding site region. A third (type 3) does not possess the epitope for the inhibitory anti-(rabbit GH receptor) MAb, appears not to bind rat GH and is lost during purification. The availability of type-specific MAbs will facilitate assignment of specific functions to liver receptor subtypes which mediate the multiple functions of GH.
我们描述了使用四种针对兔肝脏生长激素(GH)受体的单克隆抗体(MAb)以及一种针对纯化的大鼠肝脏GH受体产生的单克隆抗体,来表征在激素结合区域存在差异的肝脏受体亚型。抗(大鼠肝脏GH受体)单克隆抗体既能抑制又能沉淀大鼠和兔的GH受体,但过量抗体只能抑制125I - oGH(绵羊GH)与肝脏微粒体结合的一半。相反,过量的oGH只能抑制125I - 抗(大鼠GH受体)单克隆抗体结合的一半,并且该单克隆抗体的Scatchard图显示有两个成分。尽管该单克隆抗体只能抑制125I - oGH与膜结合的50%,但所有可溶解的受体都能被免疫沉淀。我们推测抗(大鼠GH受体)单克隆抗体有两个表位,一个位于激素结合位点(抑制位点),另一个在其他位置(免疫沉淀位点)。第二种兔特异性抗体(单克隆抗体7)能抑制85%的激素结合,但只能抑制125I - 抗(大鼠GH受体)单克隆抗体与兔肝脏微粒体结合的30%。该单克隆抗体与抗(大鼠GH受体)单克隆抗体联合使用能完全抑制125I - oGH结合。单独使用单克隆抗体7能完全抑制125I - 大鼠GH与兔肝脏微粒体结合,对125I - oGH与纯化受体的结合也是如此。基于这些结果及其他结果,我们推测兔肝脏膜中有三种类型的GH受体,并确定了125I - oGH与每种受体结合的大致比例。一种不可被聚乙二醇沉淀的胞质“GH受体”被证明与“2型”微粒体受体有五个共同表位。从兔肝脏微粒体制备物中纯化得到的质膜和内质网部分在GH结合区域具有相同的抗原特性,这表明我们所描述的异质性与受体加工无关。在兔(可能还有大鼠)质膜中的三种类型的GH受体中,我们推测一种(1型)对应于参与刺激生长的GH受体,并且具有此处研究的所有表位。第二种(2型)似乎与胞质“GH受体”相同,但在激素结合位点区域缺乏抗(大鼠GH受体)单克隆抗体的表位。第三种(3型)不具有抑制性抗(兔GH受体)单克隆抗体的表位,似乎不结合大鼠GH,并且在纯化过程中丢失。针对特定类型的单克隆抗体的可用性将有助于确定介导GH多种功能的肝脏受体亚型的特定功能。